Events and webinars

AI Health Law & Policy Summit

Join Hogan Lovells on 1 - 2 May 2024 for our 3rd annual AI Health Law & Policy Summit. In this informative and interactive program, our thought leaders and industry guests will address...

ABA Washington Health Law Summit | AI in Healthcare: Parting the Mist to Get to Reality

This panel “AI in Healthcare: Parting the Mist to Get to Reality” will provide a broad overview of the myriad uses for artificial intelligence in health care, including how AI...

Marketing with Health Data: A discussion of the current state and uncertainty of how and when health and life sciences companies may use health or other sensitive data in connection with marketing, advertising and other promotional activities in the U.S.

Use of health and sensitive data in connection with US marketing activities has grown complex. Most recently, focus has been on the use of tracking technologies. FTC enforcement actions in...

Biomed Israel: 2023 Regulatory outlook: Medical technology trends shaping the future

In this lunch symposium at Biomed Israel 2023, the Hogan Lovells team will provide an overview of the current EU and U.S. medical technology landscape and examine the trends shaping the...

Cybersecurity Preparedness in Three “Acts” – Is Your Organization Prepared?

Join us for our exclusive cybersecurity program and networking opportunity in partnership with Optiv, a leading cybersecurity advisory and solutions specialist, and Western Union, a...

Unpacking the prescription drug provisions of the Inflation Reduction Act of 2022

On 7 August, 2022, the Senate passed the proposed Inflation Reduction Act of 2022, which includes a number of significant prescription drug-related provisions. The bill generally revives...

Health Care AI Law and Policy Summit

Creation and adoption of artificial intelligence (AI) systems promise better health care management for patients and faster, more accurate diagnoses for doctors. Companies pursuing AI...

WTO IP rights: The future of products combating COVID-19

The Biden Administration recently announced that it would support the request for a World Trade Organization (WTO) waiver of intellectual property (IP) rights under the WTO Agreement on...

Loading data